Wells Fargo & Company MN Buys 29,626 Shares of Diversified Healthcare Trust (NASDAQ:DHC)

Wells Fargo & Company MN raised its stake in Diversified Healthcare Trust (NASDAQ:DHC) by 27.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 139,393 shares of the real estate investment trust’s stock after purchasing an additional 29,626 shares during the period. Wells Fargo & Company MN owned 0.06% of Diversified Healthcare Trust worth $321,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Cibc World Markets Corp bought a new position in Diversified Healthcare Trust in the fourth quarter valued at about $990,000. JPMorgan Chase & Co. grew its holdings in Diversified Healthcare Trust by 42.8% during the 4th quarter. JPMorgan Chase & Co. now owns 1,233,790 shares of the real estate investment trust’s stock worth $2,838,000 after acquiring an additional 369,984 shares during the period. Barclays PLC boosted its stake in Diversified Healthcare Trust by 310.2% during the third quarter. Barclays PLC now owns 324,514 shares of the real estate investment trust’s stock worth $1,360,000 after acquiring an additional 245,405 shares in the last quarter. Prudential Financial Inc. increased its holdings in shares of Diversified Healthcare Trust by 15.4% during the fourth quarter. Prudential Financial Inc. now owns 1,804,078 shares of the real estate investment trust’s stock valued at $4,149,000 after acquiring an additional 241,400 shares in the last quarter. Finally, ING Groep NV bought a new position in Diversified Healthcare Trust in the 4th quarter valued at about $460,000. 75.98% of the stock is owned by institutional investors.

Diversified Healthcare Trust Stock Down 4.0 %

DHC opened at $2.18 on Tuesday. The firm has a market capitalization of $525.89 million, a P/E ratio of -1.35 and a beta of 2.37. Diversified Healthcare Trust has a one year low of $2.00 and a one year high of $4.24. The company has a fifty day moving average price of $2.40 and a 200-day moving average price of $2.50. The company has a debt-to-equity ratio of 1.44, a current ratio of 11.57 and a quick ratio of 11.57.

Diversified Healthcare Trust (NASDAQ:DHC) last issued its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.31. The firm had revenue of $379.62 million during the quarter, compared to the consensus estimate of $370.97 million. Diversified Healthcare Trust had a negative return on equity of 17.55% and a negative net margin of 26.09%.

Diversified Healthcare Trust Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Tuesday, April 22nd will be paid a $0.01 dividend. The ex-dividend date of this dividend is Tuesday, April 22nd. This represents a $0.04 dividend on an annualized basis and a yield of 1.83%. Diversified Healthcare Trust’s dividend payout ratio is presently -2.60%.

Analyst Upgrades and Downgrades

DHC has been the subject of several research reports. B. Riley began coverage on shares of Diversified Healthcare Trust in a research report on Thursday, April 3rd. They set a “buy” rating and a $4.50 price target for the company. StockNews.com upgraded shares of Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a research note on Thursday, April 10th.

Diversified Healthcare Trust Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.